A community oncology pharmacist explains how seeing patients across the course of their diagnosis builds trust and why accessibility remains the field’s biggest challenge despite advances in AI.
|Videos|April 22, 2013
Patrick Gleason on Split-Fill Programs for Specialty Medications
Patrick Gleason, PharmD, BCPS, FCCP, director of health outcomes for Prime Therapeutics, explains how split-fill programs can help reduce waste for expensive specialty medications.
Advertisement
Patrick Gleason, PharmD, BCPS, FCCP, director of health outcomes for Prime Therapeutics, explains how split-fill programs can help reduce waste for expensive specialty medications.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
AHA 2026: Pharmacists at the Center of Cardiometabolic Care
2
From Recognition to Prior Authorization: ATTR-CM Diagnosis Gaps
3
FDA Approves Perioperative Durvalumab Plus Enfortumab Vedotin-ejfv for MIBC
4
Pneumococcal Vaccines Show Moderate Immunogenicity, Strong Safety in Children With Cancer
5